DS
ALDR

DRW Securities’s Alder Biopharmaceuticals ALDR Stock Holding History

DRW Securities’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25,003
Closed -$472K – 292
2019
Q3 		$472K Buy
+25,003
New +$286K 0.03% 100

DRW Securities's ALDR Position: Q4 2019 in Review

DRW Securities sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 25,003 shares — an estimated $472K sold.

DRW Securities first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $472K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • DRW Securities reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • DRW Securities sold 25,003 Alder Biopharmaceuticals shares in Q4 2019, an estimated $472K.
  • DRW Securities first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • DRW Securities's Alder Biopharmaceuticals position peaked at $472K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on DRW Securities's 13F filing for Q4 2019, filed 12 Feb 2020.